Document Details
Form
Filing Date
Oct 31, 2024
Document Date
Oct 31, 2024
Form Description
SCHEDULE 13G/A - Description
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
